Page last updated: 2024-09-05

atropine and dmp 696

atropine has been researched along with dmp 696 in 1 studies

Compound Research Comparison

Studies
(atropine)
Trials
(atropine)
Recent Studies (post-2010)
(atropine)
Studies
(dmp 696)
Trials
(dmp 696)
Recent Studies (post-2010) (dmp 696)
26,7111,2591,6973104

Protein Interaction Comparison

ProteinTaxonomyatropine (IC50)dmp 696 (IC50)
Histamine H1 receptorCavia porcellus (domestic guinea pig)0.0398
Corticotropin-releasing factor receptor 1Homo sapiens (human)0.0504
Corticotropin-releasing factor receptor 1Rattus norvegicus (Norway rat)0.0042

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arneric, SP; Bai, S; Clarke, T; Fitzgerald, L; Gilligan, PJ; Grossman, S; Hartig, P; He, L; Heman, K; Krause, C; Lelas, S; Li, YW; Marshall, A; McElroy, JF; Miller, K; Robertson, D; Saye, J; Trainor, G; Ward, K; Wong, H; Zaczek, R; Zeller, K; Zhang, G1

Other Studies

1 other study(ies) available for atropine and dmp 696

ArticleYear
Synthesis and structure-activity relationships of 8-(pyrid-3-yl)pyrazolo[1,5-a]-1,3,5-triazines: potent, orally bioavailable corticotropin releasing factor receptor-1 (CRF1) antagonists.
    Journal of medicinal chemistry, 2009, May-14, Volume: 52, Issue:9

    Topics: Administration, Oral; Animals; Behavior, Animal; Biological Availability; Clinical Trials as Topic; Dogs; Inhibitory Concentration 50; Rats; Receptors, Corticotropin-Releasing Hormone; Solubility; Structure-Activity Relationship; Triazines; Water

2009